The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage
Open accessAbstract
BACKGROUND: Limited data are available to guide the choice of a target for the systolic blood-pressure level when treating acute hypertensive response in patients with intracerebral hemorrhage. METHODS: We randomly assigned eligible participants with intracerebral hemorrhage (volume, <60 cm(3)) and a Glasgow Coma Scale (GCS) score of 5 or more (on a scale from 3 to 15, with lower scores indicating worse condition) to a systolic blood-pressure target of 110 to 139 mm Hg (intensive treatment) or a target of 140 to 179 mm Hg (standard treatment) in order to test the superiority of intensive reduction of systolic blood pressure to standard reduction; intravenous nicardipine to lower blood pressure was administered within 4.5 hours after symptom onset. The primary outcome was death or disability (modified Rankin scale score of 4 to 6, on a scale ranging from 0 [no symptoms] to 6 [death]) at 3 months after randomization, as ascertained by an investigator who was unaware of the treatment assignments. RESULTS: Among 1000 participants with a mean (±SD) systolic blood pressure of 200.6±27.0 mm Hg at baseline, 500 were assigned to intensive treatment and 500 to standard treatment. The mean age of the patients was 61.9 years, and 56.2% were Asian. Enrollment was stopped because of futility after a prespecified interim analysis. The primary outcome of death or disability was observed in 38.7% of the participants (186 of 481) in the intensive-treatment group and in 37.7% (181 of 480) in the standard-treatment group (relative risk, 1.04; 95% confidence interval, 0.85 to 1.27; analysis was adjusted for age, initial GCS score, and presence or absence of intraventricular hemorrhage). Serious adverse events occurring within 72 hours after randomization that were considered by the site investigator to be related to treatment were reported in 1.6% of the patients in the intensive-treatment group and in 1.2% of those in the standard-treatment group. The rate of renal adverse events within 7 days after randomization was significantly higher in the intensive-treatment group than in the standard-treatment group (9.0% vs. 4.0%, P=0.002). CONCLUSIONS: The treatment of participants with intracerebral hemorrhage to achieve a target systolic blood pressure of 110 to 139 mm Hg did not result in a lower rate of death or disability than standard reduction to a target of 140 to 179 mm Hg. (Funded by the National Institute of Neurological Disorders and Stroke and the National Cerebral and Cardiovascular Center; ATACH-2 ClinicalTrials.gov number, NCT01176565 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage
Anderson, C. S., Heeley, E., Huang, Y., Wang, J., Stapf, C., Delcourt, C., Lindley, R., Robinson, T., Lavados, P., Neal, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214609 · Cited by 1,614
US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model
Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005) · Medical Care · doi:10.1097/00005650-200503000-00003 · Cited by 1,274
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Mayer, S. A., Brun, N. C., Begtrup, K., Broderick, J., Davis, S., Diringer, M. N., Skolnick, B. E., & Steiner, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042991 · Cited by 1,167
Self-citationBroderick, J., Connolly, S., Feldmann, E., Hanley, D., Kase, C., Krieger, D., Mayberg, M., Morgenstern, L., Ogilvy, C. S., Vespa, P., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.183689 · Cited by 1,125
Self-citationRecombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Mayer, S. A. (2007) · Stroke · doi:10.1161/01.str.0000254499.46122.22 · Cited by 1,034
Enlargement of Spontaneous Intracerebral Hemorrhage: Incidence and Time Course
Kazui, S., Naritomi, H., Yamamoto, H., Sawada, T., & Yamaguchi, T. (1996) · Stroke · doi:10.1161/01.str.27.10.1783 · Cited by 572
Self-citationQureshi, A. I., Ezzeddine, M. A., Nasar, A., Suri, M. F. K., Kirmani, J. F., Hussein, H. M., Divani, A. A., & Reddi, A. S. (2007) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2006.07.008 · Cited by 459
Self-citation(2006) · Cerebrovascular Diseases · doi:10.1159/000094831 · Cited by 411
Early care limitations independently predict mortality after intracerebral hemorrhage
Zahuranec, D. B., Brown, D. L., Lisabeth, L. D., Gonzales, N. R., Longwell, P. J., Smith, M. A., Garcia, N. M., & Morgenstern, L. B. (2007) · Neurology · doi:10.1212/01.wnl.0000261906.93238.72 · Cited by 324
Determinants of Intracerebral Hemorrhage Growth: An Exploratory Analysis
Broderick, J. P., Diringer, M. N., Hill, M. D., Brun, N. C., Mayer, S. A., Steiner, T., Skolnick, B. E., & Davis, S. M. (2007) · Stroke · doi:10.1161/01.str.0000258078.35316.30 · Cited by 322
Self-citationRelation Between Blood Pressure and Outcome in Intracerebral Hemorrhage
Dandapani, B. K., Suzuki, S., Kelley, R. E., Reyes-Iglesias, Y., & DUNCAN, R. C. (1995) · Stroke · doi:10.1161/01.str.26.1.21 · Cited by 273
Anderson, C. S., Huang, Y., Arima, H., Heeley, E., Skulina, C., Parsons, M. W., Peng, B., Li, Q., Su, S., Tao, Q. L., et al. (2010) · Stroke · doi:10.1161/strokeaha.109.561795 · Cited by 257
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: Design, Methods, and Rationale
Qureshi, A. I., & Palesch, Y. Y. (2011) · Neurocritical Care · doi:10.1007/s12028-011-9538-3 · Cited by 229
Self-citationQureshi, A. I. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.61 · Cited by 224
Self-citationSafety and Tolerability of NXY-059 for Acute Intracerebral Hemorrhage: The CHANT Trial
Lyden, P. D., Shuaib, A., Lees, K. R., Davalos, A., Davis, S. M., Diener, H.-C., Grotta, J. C., Ashwood, T. J., Hardemark, H.-G., Svensson, H. H., et al. (2007) · Stroke · doi:10.1161/strokeaha.106.472746 · Cited by 174
Blood Pressure Variability and Clinical Outcome in Patients with Acute Intracerebral Hemorrhage
Lattanzi, S., Cagnetti, C., Provinciali, L., & Silvestrini, M. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.03.014 · Cited by 94
Arima, H., Anderson, C. S., Wang, J. G., Huang, Y., Heeley, E. L., Neal, B. C., Woodward, M., Skulina, C., Parsons, M. W., Peng, B., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.154328 · Cited by 88
Sykora, M., Diedler, J., Turčáni, P., Rupp, A., & Steiner, T. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.04.028 · Cited by 51
Self-citationQureshi, A. I., Palesch, Y. Y., Martin, R. H., Toyoda, Ḱ., Yamamoto, H., Wang, Y., Wang, Y., Hsu, C. Y., Yoon, B., Steiner, T., et al. (2014) · Europe PMC (PubMed Central) · Cited by 37
Self-citationIntracerebral Hemorrhage Specific Intensity of Care Quality Metrics
Qureshi, A. I. (2010) · Neurocritical Care · doi:10.1007/s12028-010-9453-z · Cited by 33
Self-citation
Cited by
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Metadata
- Authors
- Qureshi, A. I., Palesch, Y. Y., Barsan, W. G., Hanley, D. F., Hsu, C. Y., Martin, R. L., Moy, C. S., Silbergleit, R., Steiner, T., Suarez, J. I., Toyoda, K., Wang, Y., Yamamoto, H., & Yoon, B.-W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-09-15
- Volume
- 375
- Issue
- 11
- Pages
- 1033-1043
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2409181187
- Cited by
- 1,124
- References
- 20
- FWCI
- 74.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.